RBL Communications
  • Home
  • About
  • Services
  • Investment Hub
  • Contact
Select Page

Revive Therapeutics Announces Filing of a Pre-CTA Meeting Request with Health Canada and Update on U.S. FDA IND Filing and Phase 3 Clinical Trial Design for Bucillamine in the Treatment of COVID-19

Jun 4, 2020

TORONTO, June 03, 2020 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has filed its...

Revive Therapeutics Provides Corporate Update on its Pharmaceutical Initiatives

May 13, 2020

TORONTO, May 13, 2020 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide a corporate update on...

Kontrol Energy Launches Enterprise Software Pilots with Leading European Original Equipment Manufacturer

May 13, 2020

–Global Smart Buildings Market– TORONTO, ON / May 13, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company”) is pleased to announce that it will launch multiple enterprise energy management software...

Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program

Apr 29, 2020

TORONTO, April 29, 2020 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide further insight on...

Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial

Apr 23, 2020

TORONTO, April 23, 2020 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today that it has received...

Kontrol Energy Addresses Impact of Decline in Oil Prices on Its Operations

Apr 22, 2020

TORONTO, ON / April 22, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company”) a leader in the energy efficiency sector through IoT, Cloud and SaaS technology addresses the impact of the decline in oil prices on...
« Older Entries
Next Entries »

Follow Us

Categories

  • Al O'Grady
  • Anfield Energy
  • Blog
  • Boba Mint Holdings
  • Kontrol Energy
  • News
  • PharmaDrug
  • Revive
  • Uncategorized
  • Home
  • About
  • Services
  • Investment Hub
  • Contact
  • Facebook
  • X
© COPYRIGHT 2025. RBL Communications Inc. ALL RIGHTS RESERVED.